NCT06885346

Probiotics Improve Adult Allergic Rhinitis and Regulate Gut Microbiota

The Effectiveness of Weizmannia Coagulans BC99 in Alleviating Allergic Rhinitis in Adults and Its Impact on the Gut Microbiota

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 78 (actual)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Assessing the clinical efficacy of weizmannia coagulans BC99 in alleviating allergic rhinitis symptoms, improving gut microbiota, and reducing adverse reactions in patients.

Conditions

• Allergic Rhinitis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	The experimental phase of this study lasts for 8 weeks, with each patient making three visits at weeks 1, 4, and 8.
DIETARY_SUPPLEMENT	Placebo	The experimental phase of this study lasts for 8 weeks, with each patient making three visits at weeks 1, 4, and 8.

Timeline

• Start date: 2024-11-02
• Primary completion: 2024-12-28
• Completion: 2025-02-25
• First posted: 2025-03-20
• Last updated: 2025-03-20

Locations

1 site across 1 country: China